Renewed double-digit sales growth "pushes" HARTING Technology Group ahead / Sales up 13.4% to EUR762 million / 341 new jobs worldwide (FOTO)
mehr
Ergebnis der Suchanfrage nach Wirtschaft
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
405 Treffer
BDI Bundesverband der Deutschen Industrie
BDI on the pending EU Special Summit: Industry expects a clear sign of agreement
Berlin (ots) - Regarding the fundamental agreement between the Brexit negotiators on a political declaration and ahead of the EU Special Summit on Sunday, BDI Director General Joachim Lang says: "Industry expects a clear sign of agreement" - "I'm expecting a clear sign of agreement from the Brexit Special Summit. Reopening the negotiations is not the way forward. - ...
mehrVDA - Verband der Automobilindustrie e.V.
Mattes: IAA Commercial Vehicles exceeds our expectations
Hannover/Berlin (ots) - Leading international trade show sets new standards with 435 world premieres and 282,000 sq m - Very many purchasing agreements - Focus on digitization, electric mobility and urban logistics - High-quality visitors - Strong presence also on social media This IAA certainly has a well-chosen slogan: "Driving tomorrow." Today I can say that this aspiration - to comprehensively present the future of ...
mehr- 2
GERRY WEBER - Eva Herzigova remains the face of the brand in 2018
mehr EANS-Adhoc: ams AG / ams surprised by allegations in "Finanz & Wirtschaft" newspaper
issuer: ams AG Tobelbader Strasse 30 A-8141 Unterpremstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com sector: Technology ISIN: AT0000A18XM4 indexes: stockmarkets: official dealing: SIX Swiss Exchange language: English ...
mehrHelaba with stable business and earnings development in first half- year
Frankfurt am Main (ots) - - Net interest income rises by 10 per cent - Substantial fall in provisions for loans and advances - CET-1 ratio reaches 12.9 per cent - Annual earnings projected to be in line with targets - Joint venture in foreign trade finance In the first half of 2014, Helaba achieved earnings before tax of EUR 322 million, a result that was only slightly ...
mehr
Helaba achieves significant improvement in first half of 2013
Frankfurt (ots) - - Group earnings grow by more than 18 per cent - Buoyant new business volume with satisfactory margins - Outlook for year cautiously optimistic Helaba, Landesbank Hessen-Thüringen, continued its upward growth trend in the first half of 2013. It achieved group- wide earnings before taxes of EUR 336 million, surpassing the result of the ...
Ein DokumentmehrFreiburg Wirtschaft Touristik und Messe GmbH & Co. KG
Freiburg Green City / Green Growth: Investments in renewable energies boost local economy
Freiburg (ots) - Freiburg represents the successful integration of former opposites - ecology and economy. Environmentally sound policies, solar energy technologies, sustainability and environmental protection have become one of the driving forces behind economic, political and urban development. With around 12,000 employees - nearly three per cent of the economically ...
mehrEANS-Adhoc: AGRANA Beteiligungs-AG / AGM approves unchanged dividend
Further inquiry note: Investor Realtions: Mag. Maria Fally Tel.: 01-21137-12905 maria.fally@agrana.com Public Relations: Mag. Ulrike Pichler Tel.: 01-21137-12084 ulrike.pichler@agrana.com Branche: Food ISIN: AT0000603709 WKN: 779535 Index: WBI, ATX Prime Börsen: Berlin / Präsenzhandel Frankfurt / Präsenzhandel Stuttgart / Präsenzhandel Wien / official market ...
mehrBoehringer Ingelheim Receives Approval From the European Commission for Mirapexin(R)/Sifrol(R) Prolonged-Release, Once Daily Tablet for the Treatment of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - New Formulation Brings the Established Efficacy of Mirapexin(R)/Sifrol(R) to Patients With Parkinson's Disease in the Convenience of a Once Daily Dose Boehringer Ingelheim today announced that the Mirapexin(R)/Sifrol(R) (pramipexole) new prolonged-release , once daily tablet ...
mehrEANS-Adhoc: AGRANA Beteiligungs-AG / AGM approves unchanged dividend
Further inquiry note: Investor Realtions: Mag. Maria Fally Tel.: 01-21137-12905 maria.fally@agrana.com Public Relations: Mag. Ulrike Pichler Tel.: 01-21137-12084 ulrike.pichler@agrana.com Branche: Food ISIN: AT0000603709 WKN: 779535 Index: WBI, ATX Prime Börsen: Berlin / Präsenzhandel Frankfurt / Präsenzhandel Stuttgart / Präsenzhandel Wien / official market ...
mehrEuropean Commission Approves Statement on Lipid Improvement for VIRAMUNE(R) Label
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical Products ...
mehr
Delticom enjoys strong growth despite unfavorable climate
- Preliminary revenues in H1 2008 up 19% year-on-year - More than 340,000 new customers - Foreign revenues at high level of 65% Further inquiry note: Contact: Company Delticom AG Investor Relations Melanie Gereke Brühlstraße 11 30169 Hanover Tel.: +49 (0)511-936 34-8903 Fax: +49 (0)89-208081147 e-mail: melanie.gereke@delti.com IR Agency cometis AG Henryk Deter Unter den Eichen 7 65195 Wiesbaden Tel.: +49 ...
mehrNew Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It ...
mehrFDA Approves Boehringer Ingelheim's Pramipexole for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
Ingelheim, Germany, November 10 (ots/PRNewswire) - - Millions of People Worldwide Living With RLS to Benefit as Treatment Becomes Globally Available Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the ...
mehr
Vorherige567891011121314